The AHA released a scientific statement on tailored exercise training for patients with high-risk cardiovascular conditions.

The American Heart Association issued a scientific statement on deprescribing for patients with cardiovascular disease and polypharmacy.

Kalshi and AppliedXL launch a pilot prediction market for late-stage clinical trial outcomes and FDA decisions using objective public data sources.

Finerenone plus empagliflozin combination therapy reduces systolic blood pressure in patients with T2D and chronic kidney disease.

A cohort study indicates prepregnancy BMI and race, ethnicity interact to influence the prevalence and risk for preeclampsia, eclampsia.

Postmenopausal women with a history of migraine may have an increased risk for ischemic stroke, according to recent study findings.

Patients with continuous public insurance or frequent coverage changes face higher mortality and graft failure risk after heart transplantation.

Center volume for fetal aortic valvuloplasty is not associated with technical success or complications but is linked to lower periprocedural death.

The FDA has granted Fast Track designation to invobenitug, an investigational anti-cDPP3 monoclonal antibody designed to restore RAAS balance in cardiogenic shock.

Benzodiazepine use among older U.S. adults decreased before the COVID-19 pandemic but plateaued thereafter, according to a research letter published online Jul ...

Bariatric surgery may increase the risk for alcohol problems, according to 2 studies recently published online.

An analysis examined the systemic and individual drivers of clinician burnout and strategies to help medical professionals ...